期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Intravenous haloperidol for the treatment of intractable vomiting,cyclical vomiting,and gastroparesis
1
作者 brad e.schwartz Karen Keller Baker +2 位作者 Andrew J.Bleinberger Amina Lleshi Raul Cruz-Cano 《World Journal of Emergency Medicine》 SCIE CAS CSCD 2021年第3期228-231,共4页
Dear editor,The incidence of emergency department(ED)visits from gastroparesis and cannabinoid hyperemesis syndrome has increased by two folds over the past decade.[1-3]Roldan et al[4]reported that patients with these... Dear editor,The incidence of emergency department(ED)visits from gastroparesis and cannabinoid hyperemesis syndrome has increased by two folds over the past decade.[1-3]Roldan et al[4]reported that patients with these conditions often have prolonged ED stays and are likely to be hospitalized because of the danger of dehydration and challenges inherent in relieving symptoms.Opioid analgesia is a particularly troublesome treatment modality;these conditions are often chronic with frequent recurrences,and repeated opiate therapy can cause opioid dependency and narcotic bowel syndrome.[5]Haloperidol(HP)and droperidol,members of the butyrophenone class,have potent antidopaminergic activity in the chemoreceptor trigger zone.[6,7]Intramuscular administration of HP is being used increasingly in the ED to treat nausea,vomiting secondary to gastroparesis,[6]intractable vomiting,[8]and cyclical vomiting. 展开更多
关键词 VOMITING gastro TREATMENT
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部